Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Schmidt

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|March 13, 2026
Evaluation of Dysphagia in Myositis and Muscular Dystrophy Using Real-Time MRI and Quantitative Muscle UltrasoundRachel Zeng, Anke Rietveld, Omar Al-Bourini, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Defining anti-synthetase syndrome: a systematic literature reviewGiovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Current status of clinical outcome measures in inclusion body myositis: a systematised reviewBhaskar Roy, Matteo Lucchini, James B Lilleker, et al.
Annals of the Rheumatic Diseases|September 1, 2017
The EuroMyositis registry: an international collaborative tool to facilitate myositis researchJames B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Annals of the Rheumatic Diseases|December 21, 2017
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna <i>et al</i>James B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Brain : a Journal of Neurology|August 25, 2025
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscleJuliane Bremer, Judith Nagel, Jana Zschüntzsch, et al.
Rheumatology (Oxford, England)|September 12, 2023
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registryRyan Malcolm Hum, James B Lilleker, Janine A Lamb, et al.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating ScaleUmesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Cachexia, Sarcopenia and Muscle|March 13, 2026
Evaluation of Dysphagia in Myositis and Muscular Dystrophy Using Real-Time MRI and Quantitative Muscle UltrasoundRachel Zeng, Anke Rietveld, Omar Al-Bourini, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Defining anti-synthetase syndrome: a systematic literature reviewGiovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
Clinical and Experimental Rheumatology|February 10, 2023
Current status of clinical outcome measures in inclusion body myositis: a systematised reviewBhaskar Roy, Matteo Lucchini, James B Lilleker, et al.
Annals of the Rheumatic Diseases|September 1, 2017
The EuroMyositis registry: an international collaborative tool to facilitate myositis researchJames B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Annals of the Rheumatic Diseases|December 21, 2017
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna <i>et al</i>James B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Brain : a Journal of Neurology|August 25, 2025
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscleJuliane Bremer, Judith Nagel, Jana Zschüntzsch, et al.
Rheumatology (Oxford, England)|September 12, 2023
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registryRyan Malcolm Hum, James B Lilleker, Janine A Lamb, et al.
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating ScaleUmesh A Badrising, Robert Henderson, Stephen Reddel, et al.
Pageof 12